跳至主要内容
临床试验/NCT02493179
NCT02493179Unknown4 期

Efficacy Evaluation of the Dose Regimen of Serratiopeptidase (Serodase 5 mg Tablet) in the Treatment of Inflammation After Third Molar Surgery

Hayat Pharmaceutical Co. PLC0 个研究点目标入组 112 人开始时间: 2015年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
112
主要终点
Trimus by measuring the interincisal distance

研究概览

简要总结

The purpose of this study is to examine the efficacy of dose regimen of serratiopeptidase (serodase 5 mg) as a prospective, randomized, parallel, double blind Placebo- controlled study.

详细描述

A prospective, randomized, parallel, double blind Placebo- controlled study to examine the efficacy of dose regimen of serratiopeptidase (serodase 5 mg) on 112 males and females volunteers in the treatment of inflammation after third molar surgery, comparing drug treatment vs placebo over a period of 20 weeks To assess the dose effectiveness of the dose regimen of Serodase 5 mg; the primary outcomes are trismus and swelling while inflammation is a secondary outcome.the expected duration of participants participation will be around 5 days divided into 4 visits, the time point of the measurment are (0,2,4 and 5 days).

The results are expected to assess the improvement of the maximal interincisal distance, reduction of swelling and improvment in the sensation of post-operative pain.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • participants presented with impacted lower wisdom tooth needs Buccaneers flap with buccal and distal bone removal.
  • male or female 18-50
  • participant is willing and able to give informed consent for paricipation in the study.
  • Able and willing and able with all study requirments.

排除标准

  • other oral surgical procedures during the same session except the removal of supernumerary third molars.
  • female subject who is pregnant or lactating
  • subjects has participated in any clinical research study within the previous 8 weeks.
  • subjects on anti coagulant drugs .
  • Unwilling participants to continue the study and those with abnormality of wound healing process.

研究组 & 干预措施

Serodase 5 mg

Active Comparator

Serodase ( Serratiopeptidase) 5 mg

干预措施: Serodase 5 mg (Drug)

Placebo

Placebo Comparator

Placebo

干预措施: Placebo (Drug)

结局指标

主要结局

Trimus by measuring the interincisal distance

时间窗: 5 days

the increase in the interincisal distance will show a positive effect on the Trismus

Swelling by using The Laskin method

时间窗: 5 days

the decrease in swelling will shows a positive effect on swelling based distances at predetermined time points .

次要结局

  • Post-operative pain(5 days)

研究者

发起方
Hayat Pharmaceutical Co. PLC
申办方类型
Industry
责任方
Sponsor

相似试验